Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
- PMID: 34983600
- PMCID: PMC8724733
- DOI: 10.1186/s13054-021-03873-2
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
Abstract
ClinicalTrials.gov identifier (NCT number): NCT03852537 , Registered February 25, 2019.
Keywords: C-reactive protein; Coronavirus disease 2019; Corticosteroids.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- COVID-19 Treatment Guidelines-NIH. (COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed [11/11/21]).
-
- Dexamethasone in Hospitalized Patients with Covid-19—Preliminary Report. New England Journal of Medicine 2020. 10.1056/NEJMoa2021436.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials